A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Umit Yavuz MalkanMurat AlbayrakAbdulkerim YıldızSenem MaralHacer Berna Afacan ÖztürkPınar CömertPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
Our patients' findings are suitable for six out of eight criteria of hemaphagocytic syndrome. The H-score of our patient was more than 250, reflecting the >99% probability of HLH syndrome. Compatible with literature knowledge, our patient had responded very well to etoposide-containing regimens. In our patient, no lymphadenopathy was detected by physical examination or MR scan, and the diagnosis of DLBCL was only made by the result of bone marrow investigation. In conclusion, herein, we have reported a DLBCL case that had presented with HLH, and clinicians should be aware that B-cell lymphomas may be the underlying cause of HLH.
Keyphrases
- diffuse large b cell lymphoma
- case report
- rare case
- bone marrow
- epstein barr virus
- end stage renal disease
- chronic kidney disease
- healthcare
- ejection fraction
- systematic review
- newly diagnosed
- mesenchymal stem cells
- magnetic resonance
- mental health
- palliative care
- physical activity
- peritoneal dialysis
- patient reported outcomes
- contrast enhanced